Biotechnology Stocks I Performance Guide: Mirati Therapeutics, Inc. (MRTX)
MRTX has no dividends
Table and Chart of MRTX Performance
See what a $1,000 investment in MRTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MRTX Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $16.63 |
| End Date | Dec-01-2023 |
| End Price | $57.08 |
| # Prices | 121 |
| Min Date | May-31-2017 |
| Min Price | $2.80 |
| Max Date | Nov-30-2020 |
| Max Price | $237.85 |
| Total Return | 243.24% |
| Annualized Return | 13.01% |
| Current Value of $1,000 Purchase | $3,432 |
| Number Returns | 7,260 |
| Average Return | 401.10% |
| Number Profitable Returns | 5,213 |
| Percent Profitable Returns | 71.80% |
| Number Unprofitable Returns | 2,047 |
| Percent Unprofitable Returns | 28.20% |
| Profitable to Unprofitable Returns Ratio | 2.55 |
| MRTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $4,004,031,000 | Price to Sales | 104.84 |
| Earnings per Share | $-12.1800 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 4.231 |
| PRICE DATA | |
| 52 Week High | $80.3 |
| 52 Week Low | $27.3 |
| Analyst Target Price | $60.69 |
| 50-Day Moving Average | $53.93 |
| 200-Day Moving Average | $42.75 |
| FINANCIAL DATA | |
| Revenue per Share | $0.639 |
| Revenue | $38,191,000 |
| Profit Margin | 0% |
| Return on Equity | -0.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MRTX Compare Returns with S&P 500
MRTX Trendline Chart